[1] Whiting DR,Guariguata L,Weil C,et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030[J].Diabetes Res Clin Pract,2011,94(3): 311-321.
[2] 杨文英,李玉秀,陈莉明,等. 双时相门冬胰岛素30 在中国人群中的临床应用—A1 chieve 观察性研究结果[J].中华糖尿病杂志,2012,4( 10) : 607-612.
[3] Xu Y,Wang L,He J,et al. Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.
[4] Opsteen C,Qi Y,Zinman B,et al. Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes[J].J Eval Clin Pract,2012,18(2):256-261.
[5] 吕波. 门冬胰岛素30 联合伏格列波糖治疗2 型糖尿病临床疗效观察[J].大连医科大学学报,2013,35(5):458-460.
[6] 邬培红. 甘精胰岛素联合门冬胰岛素对血糖控制不佳的2型糖尿病患者临床疗效分析[J].实用临床医药杂志,2013,17(5):99-101.
|
2016, Vol. 33 
